Video Experimental Relacionado
Updated: Jul 10, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Los anticuerpos antifosfolípidos y la trombosis
1Department of Medicine and Therapeutics, Foresterhill, Aberdeen, UK. m.greaves@abdn.ac.uk
Lancet (London, England)
|April 28, 1999
Resumen
Los anticuerpos antifosfolípidos indican un riesgo de coágulos sanguíneos y pérdida del embarazo. La identificación del síndrome antifosfolípido es crucial para el manejo de la trombosis recurrente y la orientación de la terapia antitrombótica.
Área de la Ciencia:
- Inmunología Inmunología.
- Hematología Hematología.
- Obstetrías y Obstetricia.
Sus antecedentes:
- Los anticuerpos antifosfolípidos están relacionados con la trombosis, la pérdida de embarazo recurrente y la trombocitopenia.
- Estos anticuerpos sirven como marcadores de laboratorio clave para el síndrome antifosfolípido (APS).
Objetivo del estudio:
- Para resaltar la importancia clínica de la identificación de APS debido a los riesgos de trombosis recurrente.
- Para subrayar la necesidad de terapia antitrombótica en muchos casos de SPA.
Principales métodos:
- Revisión de las asociaciones clínicas y marcadores de laboratorio para APS.
- Análisis de los desafíos de diagnóstico y las limitaciones del tratamiento.
Principales resultados:
- La identificación de APS es crítica para el manejo de eventos trombóticos recurrentes.
- A menudo se requiere una terapia antitrombótica efectiva para los pacientes con SPA.
Conclusiones:
- El diagnóstico y el manejo de la SPA son complicados por diversas características clínicas.
- Las limitaciones en las pruebas de anticuerpos actuales y la falta de directrices basadas en la evidencia dificultan la atención óptima del paciente.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:38Inflammation
Overview
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...